Blog

Canadian cannabis sales are continuing to balloon amidst the coronavirus pandemic. The latest data from Statistics Canada show that in June, retail sales topped 201 million Canadian dollars and were

Electric-vehicle stocks have taken investors on a wild ride in recent weeks, fueling a debate about whether the stocks are overvalued.

It's not an easy time to be an investor. On one hand, it

It's estimated that 48% of Americans wind up retiring sooner than they'd like, whether due to health issues, layoffs, or other factors. On the other hand, some people specifically plan to retire

If the idea of investing in industrial stocks puts you off because it sounds boring, you'd certainly reconsider once you learn how big and vital the industrials sector is and how well-positioned

If you were wondering if Disney's (NYSE: DIS) decision to take Mulan straight to at-home audiences would pay off, the answer looks like a resounding yes. While Disney has not released specific data

Energy investors were excited as crude prices rose steadily throughout the summer. But by early September, global demand was sputtering, and Saudi Arabia cut prices to some key customers, causing

The stock market has rebounded dramatically since the COVID-19 pandemic shut down the U.S. economy in March. In fact, despite plunging by about 40% at its low point, the S&P 500 is actually up by

If you're looking to invest in the cannabis industry but don't want to worry about the risks of buying shares of pot producers, you may want to consider gardening and hydroponics company

Charlotte's Web Holdings (OTC: CWBHF) and Cresco Labs (OTC: CRLBF) are two companies getting a lot of attention in the marijuana sector after their recent earnings releases. The former is a market

The March sell-off was a doozy, and it won't be the last time that your portfolio takes a hit. Investing for gains is all about accepting the losses, and that long-term winning approach is even more

The recent sell-off in the stock market indicates that many investors are running for cover. And why not? After seeing markets tank in March in response to the COVID-19 pandemic and then hit new

Biotech superstar Amgen (NASDAQ: AMGN) finds itself in an incredibly exciting position in 2020, with a lot to look forward to in 2021. The company has a number of late-stage clinical trials due to

It's been an up-and-down year for companies across all sectors of the stock market. The volatility has been keenly felt by cannabis companies, which were severely wounded by retail closures

Not long after governments started shutting down in response to the COVID-19 pandemic, Congress passed the CARES Act in an attempt to ease the pain. That feels like a century ago. Many people have

This has been a "buckle up and hold on" type of year for investors. The unprecedented coronavirus disease 2019 (COVID-19) pandemic created a level of panic and uncertainty that Wall Street had never

Second quarter earnings season is showing investors how COVID-19 is impacting the retail landscape, and examinations of the latest earnings reports can help investors make much better decisions in

Nike (NYSE: NKE) was battered as a result of the COVID-19 outbreak. The company had to close nearly all its stores at one point, and many of its wholesale partners had to do the same. Meanwhile

With shrinking revenues, unprofitable operations, and only $45.4 million in cash against trailing-12-month operating expenses of $115.4 million, cell analysis hardware company Fluidigm (NASDAQ:

Having a diversified portfolio is essential to both growing wealth and avoiding losses in the stock market. But what exactly does a diverse portfolio entail? At a minimum, you should aim to invest

Only three coronavirus vaccine candidates with the potential to be marketed in the U.S. are currently in late-stage testing. AstraZeneca (NYSE: AZN) and Moderna (NASDAQ: MRNA) claim two of the

As Sen. Bernie Sanders, I-Vt., said in his 2016 book, Our Revolution, "Social Security is the most successful government program in our nation's history." Sanders is absolutely correct. Without

It's been a tumultuous year for the stock market, with the broad-based S&P 500 losing more than a third of its value in under five weeks, and gaining it all back in less than five months. Both the

In 1988, camera giant Eastman Kodak (NYSE: KODK) made its debut in the pharmaceutical sector by acquiring Sterling Drug for $5.1 billion. The company argued that the chemicals used in its

The latest tech company to hit the market is letting its workers hit the market, too. Unity Software (NYSE: U) said in a regulatory filing that all of its employees will be immediately allowed to

In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Brian Feroldi about the latest headlines and quarterly reports from Wall Street, including an impressive quarter for a